Information from Extraordinary General Meeting | IDL Biotech
IDL Biotech


October 2018

Information from Extraordinary General Meeting

The Extraordinary meeting was held on 2018-10-26.

Find the information from the extraordinary general meeting here

German study recommends UBC® Rapid to be added in the diagnostics and follow-up of high risk bladder cancer

International Journal of Molecular Sciences has published a study on UBC® Rapid. In total 530 urine samples was included in the multicenterstudy.

Interview with Charlotte Berg

On Saturday the 17th of November, the Swedish newspaper SvD, had an interview with the CEO, Charlotte Berg.

IDL Biotech

Skip this intro